DaVita, the Denver-based kidney-care provider, has forged its second international deal this month and will enter the dialysis market in Taiwan.

International expansion has been a growing focus for DaVita as the dialysis sector continues to feel the strain from reimbursement cuts in the U.S.

The company said in a news release that it plans to service four dialysis clinics in Taiwan through a joint venture with Riches Healthcare that will form a new entity known as DaVita Taiwan. The clinics are in or near Taipei and provide hemodialysis treatment to more than 250 patients, according to the release.

The deal comes two weeks after DaVita disclosed that it had acquired five dialysis centers in Portugal and four in Poland from Fresenius Medical Center, its main competitor in the U.S.

DaVita first invested in Germany in 2011.

Dialysis providers expect to be under new pressure this year as the American Taxpayer Relief Act of 2012 cuts billions of dollars from clinics to avoid cuts to physicians participating in Medicare.

DaVita launched its international growth plan in 2011, with agreements to provide services to 11 dialysis centers in three countries, according to its annual report for that year.

The company said it is planning to expand its international footprint through acquisitions and organic growth.